| 41 |
|
How profitable is a voluntary deductible in health insurance for the consumer?
|
van Winssen, K. P.; van Kleef, R. C.; van de Ven, W. P.
|
Elsevier : Elsevier Science Pub. Co.
|
2015
|
|
|
|
| 42 |
|
How should we regulate risk in biomedical research? An ethical analysis of recent policy proposals and initiatives
|
Rid, A.
|
Elsevier : Elsevier Science Pub. Co.
|
2014
|
|
|
|
| 43 |
|
How the Trans Pacific Partnership Agreement could undermine PHARMAC and threaten access to affordable medicines and health equity in New Zealand
|
Gleeson, D.; Lopert, R.; Reid, P.
|
Elsevier : Elsevier Science Pub. Co.
|
2013
|
|
|
|
| 44 |
|
How to evaluate population management? Transforming the Care Continuum Alliance population health guide toward a broadly applicable analytical framework
|
unknown
|
Elsevier : Elsevier Science Pub. Co.
|
2015
|
|
|
|
| 45 |
|
How to integrate research evidence on patient preferences in pharmaceutical coverage decisions and clinical practice guidelines: A qualitative study among Dutch stakeholders
|
Utens, C. M.; Dirksen, C. D.; van der Weijden, T.; Joore, M. A.
|
Elsevier : Elsevier Science Pub. Co.
|
2016
|
|
|
|
| 46 |
|
How to make medication error reporting systems work - Factors associated with their successful development and implementation
|
Holmstrom, A. R.; Laaksonen, R.; Airaksinen, M.
|
Elsevier : Elsevier Science Pub. Co.
|
2015
|
|
|
|
| 47 |
|
How to set challenging goals and conduct fair evaluation in regional public health systems. Insights from Valencia and Tuscany Regions
|
Vainieri, M.; Vola, F.; Gomez Soriano, G.; Nuti, S.
|
Elsevier : Elsevier Science Pub. Co.
|
2016
|
|
|
|
| 48 |
|
HTA of medical devices: Challenges and ideas for the future from a European perspective
|
Fuchs, Sabine; Olberg, Britta; Panteli, Dimitra; Perleth, Matthias; Busse, Reinhard
|
Elsevier : Elsevier Science Pub. Co.
|
2017
|
|
|
|